An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.
Increase in opioid epidemic in the U.S. coupled with establishment of government policies to control the crisis is driving the market.
Market Analysis and Insights: Global Opioid Use Disorder Market
In 2019, the global Opioid Use Disorder market size was US$ 1696.7 million and it is expected to reach US$ 2516.6 million by the end of 2026, with a CAGR of 5.7% during 2021-2026.
Global Opioid Use Disorder Scope and Market Size
Opioid Use Disorder market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Use Disorder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Opioid Use Disorder market is segmented into Buprenorphine, Methadone, Naltrexone, etc.
Segment by Application, the Opioid Use Disorder market is segmented into Moderate Pain Treatment, Severe Pain Treatment, etc.
Regional and Country-level Analysis
The Opioid Use Disorder market is analysed and market size information is provided by regions (countries).
The key regions covered in the Opioid Use Disorder market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Opioid Use Disorder Market Share Analysis
Opioid Use Disorder market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Opioid Use Disorder business, the date to enter into the Opioid Use Disorder market, Opioid Use Disorder product introduction, recent developments, etc.
The major vendors include Indivior, Alkermes, Titan Pharmaceuticals, Hikma Pharmaceuticals, Teva Pharmaceuticals, MediciNova, Orexo, Camurus, Omeros, etc.

This report focuses on the global Opioid Use Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Opioid Use Disorder development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Indivior
Alkermes
Titan Pharmaceuticals
Hikma Pharmaceuticals
Teva Pharmaceuticals
MediciNova
Orexo
Camurus
Omeros

Market segment by Type, the product can be split into

Buprenorphine
Methadone
Naltrexone

Market segment by Application, split into

Moderate Pain Treatment
Severe Pain Treatment

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Opioid Use Disorder status, future forecast, growth opportunity, key market and key players.
To present the Opioid Use Disorder development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Opioid Use Disorder are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.